Intel faces challenges as it surpasses Q4 estimates but struggles with weak demand, competition, and CEO transition.
Hamas orchestrates hostage releases as public spectacles, heightening regional tensions and drawing international criticism for the psychological impact on captives.
Roche reports strong 2024 results, with sales growth and plans to increase dividend for the 38th consecutive year.
Intel faces challenges as it surpasses Q4 estimates but struggles with weak demand, competition, and CEO transition.
Hamas orchestrates hostage releases as public spectacles, heightening regional tensions and drawing international criticism for the psychological impact on captives.
Roche reports strong 2024 results, with sales growth and plans to increase dividend for the 38th consecutive year.